PEAK6 Investments’s ClearPoint Neuro CLPT Stock Holding History

PEAK6 Investments’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,498	Closed	-$186K	–	5176
2021 Q3	$186K	Buy	+10,498	New	+$197K	﹤0.01%	4046

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return

GPC

Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

PEAK6 Investments's CLPT Position: Q4 2021 in Review

PEAK6 Investments sold out of ClearPoint Neuro (CLPT) in Q4 2021, closing a stake of 10,498 shares — an estimated $186K sold.

PEAK6 Investments first reported a position in CLPT in Q3 2021 and held it in 1 quarter. The position peaked at $186K in Q3 2021. 67 funds tracked by Wall St. Rank hold CLPT as of Q4 2021.

PEAK6 Investments reported no remaining ClearPoint Neuro position as of Q4 2021 after selling out during the quarter.
PEAK6 Investments sold 10,498 ClearPoint Neuro shares in Q4 2021, an estimated $186K.
PEAK6 Investments first reported a position in ClearPoint Neuro in Q3 2021 and held it in 1 quarter.
PEAK6 Investments's ClearPoint Neuro position peaked at $186K in Q3 2021.
67 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2021.

Based on PEAK6 Investments's 13F filing for Q4 2021, filed 11 Feb 2022.